Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study.
Hatta K, Katayama S, Ishizuka T, Sudo Y, Nakamura M, Hasegawa H, Imai A, Morikawa F, Shimada T, Misawa F, Ozaki S, Fujita K, Watanabe H, Nakamura H, Sugiyama N; JAST study group. Hatta K, et al. Among authors: sudo y. Asian J Psychiatr. 2022 Jan;67:102917. doi: 10.1016/j.ajp.2021.102917. Epub 2021 Nov 6. Asian J Psychiatr. 2022. PMID: 34875558 Free article.
A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Hatta K, Otachi T, Sudo Y, Kuga H, Takebayashi H, Hayashi H, Ishii R, Kasuya M, Hayakawa T, Morikawa F, Hata K, Nakamura M, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: sudo y. Psychiatry Res. 2012 Jul 30;198(2):194-201. doi: 10.1016/j.psychres.2012.01.006. Epub 2012 Mar 13. Psychiatry Res. 2012. PMID: 22421064 Clinical Trial.
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia.
Hatta K, Takebayashi H, Sudo Y, Katayama S, Kasuya M, Shirai Y, Morikawa F, Nakase R, Nakamura M, Ito S, Kuga H, Nakamura M, Ohnuma T, Usui C, Nakamura H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: sudo y. Psychiatry Res. 2013 Dec 15;210(2):396-401. doi: 10.1016/j.psychres.2013.07.005. Epub 2013 Aug 4. Psychiatry Res. 2013. PMID: 23919898 Clinical Trial.
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: sudo y. Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31. Schizophr Res. 2014. PMID: 25086659 Free article. Clinical Trial.
Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.
Hatta K, Hasegawa H, Imai A, Sudo Y, Morikawa F, Katayama S, Watanabe H, Ishizuka T, Nakamura M, Misawa F, Fujita K, Ozaki S, Umeda K, Nakamura H, Sawa Y, Sugiyama N; JAST study group. Hatta K, et al. Among authors: sudo y. Asian J Psychiatr. 2019 Feb;40:82-87. doi: 10.1016/j.ajp.2019.02.005. Epub 2019 Feb 8. Asian J Psychiatr. 2019. PMID: 30772732
Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
Hatta K, Sato K, Hamakawa H, Takebayashi H, Kimura N, Ochi S, Sudo Y, Asukai N, Nakamura H, Usui C, Kawabata T, Hirata T, Sawa Y. Hatta K, et al. Among authors: sudo y. Schizophr Res. 2009 Aug;113(1):49-55. doi: 10.1016/j.schres.2009.05.030. Epub 2009 Jun 24. Schizophr Res. 2009. PMID: 19553086 Clinical Trial.
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.
Hatta K, Otachi T, Sudo Y, Hayakawa T, Ashizawa Y, Takebayashi H, Hayashi N, Hamakawa H, Ito S, Nakase R, Usui C, Nakamura H, Hirata T, Sawa Y; JAST Study Group. Hatta K, et al. Among authors: sudo y. Schizophr Res. 2011 May;128(1-3):127-35. doi: 10.1016/j.schres.2011.02.011. Epub 2011 Mar 21. Schizophr Res. 2011. PMID: 21420283 Clinical Trial.
A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Hatta K, Katayama S, Morikawa F, Imai A, Fujita K, Fujita A, Ishizuka T, Abe T, Sudo Y, Hashimoto K, Usui C, Nakamura H, Yamanouchi Y, Hirata T; JAST study group. Hatta K, et al. Among authors: sudo y. Neuropsychopharmacol Rep. 2018 Sep;38(3):117-123. doi: 10.1002/npr2.12015. Epub 2018 May 24. Neuropsychopharmacol Rep. 2018. PMID: 30175524 Free PMC article.
627 results